Novartis new two-year data with Certican shows positive outcomes at 24 months ... Equities.com Release date- 12112012 - Basel, Novartis today announced new two-year results from the largest Phase III study ever in liver transplantation that confirmed comparable efficacy to control and superior renal function results previously seen at 12 months [1]. Novartis' Certican succeeds in liver transplant trial Novartis reports positive data from phase III Certican trial Novartis Drug Certican Shows Positive Results After Phase-III Study |
